Valproic Acid

Generic Name: Valproic Acid
Common Brand Names: Depakene, Depakote

Introduction

Valproic acid is an anticonvulsant and mood-stabilizing drug primarily used in the treatment of epilepsy and bipolar disorder. It is also used in the prevention of migraines.

Conditions of Use (Indications)

  1. Epilepsy: Used to treat various types of seizures, including generalized tonic-clonic, absence, and partial seizures.
  2. Bipolar Disorder: As a mood stabilizer, valproic acid is used to treat manic episodes in patients with bipolar disorder.
  3. Migraine Prophylaxis: It is used off-label to prevent migraines.
  4. Neuropathic Pain: Occasionally used for the treatment of neuropathic pain, though this is not a first-line therapy.

Mechanism of Action

Valproic acid works by increasing the levels of gamma-aminobutyric acid (GABA) in the brain, which is an inhibitory neurotransmitter. It also inhibits voltage-gated sodium channels and may reduce the excitability of neurons. This combination of actions helps to control seizures and stabilize mood in bipolar disorder.

Side Effects

1. Common:

  • Nausea, vomiting, and gastrointestinal upset.
  • Tremors, drowsiness, and dizziness.
  • Weight gain and hair loss.

2. Serious:

  • Hepatotoxicity, especially in children under 2 years old.
  • Pancreatitis (inflammation of the pancreas).
  • Teratogenic effects, leading to birth defects (contraindicated in pregnancy unless no alternative is available).
  • Risk of suicidal thoughts and behaviors.

Harmful Interactions

  1. Carbamazepine: Co-administration with carbamazepine may reduce the effectiveness of valproic acid.
  2. Lamotrigine: The use of valproic acid can increase the levels of lamotrigine, leading to a risk of serious rashes (e.g., Stevens-Johnson syndrome).
  3. Aspirin: Use with aspirin can increase the risk of bleeding and liver toxicity.

Contraindications

  1. Known hypersensitivity to valproic acid.
  2. Severe liver disease or a history of liver dysfunction.
  3. Pregnancy (due to high teratogenic risk, unless no other treatment is effective).
  4. Pancreatitis or a history of pancreatitis.

Latest References

  1. Kanner, A. M., et al. (2023). “Valproic Acid in the Management of Epilepsy and Bipolar Disorder.” Epilepsia, DOI: 10.1111/epi.16879.
  2. American Psychiatric Association (APA). (2022). “Mood Stabilizers and Anticonvulsants in Bipolar Disorder.” APA Guidelines.